REALQUALITY RS-WT-1

REALQUALITY RS-WT-1 is an advanced molecular diagnostic kit designed for the accurate detection and quantification of WT1 (Wilms Tumor 1)
gene expression using real-time PCR technology. That kit expression levels are widely recognized as one of the most reliable
independent biomarkers for MRD (Minimal Residual Disease) monitoring in patients with acute leukemias (AML, ALL)
and myelodysplastic syndromes (MDS). This kit enables laboratories to evaluate disease burden, assess treatment response,
and detect early signs of relapse in hematological patients.

Key Features REALQUALITY RS-WT-1

• Accurate quantification of WT1 gene expression for MRD evaluation
• Useful for treatment response monitoring, prognostic assessment, and early relapse detection
• Aligned with international guidelines and EAC standards
• Includes an internal control for result validation
• Compatible with leading Real-Time PCR instruments
• Validated for peripheral blood and bone marrow samples

Clinical Applications 

• Monitoring MRD in AML and ALL patients
• Evaluating therapeutic response after induction or consolidation therapy
• Detecting risk of early relapse during follow-up
• Assessment of disease progression in MDS

🇮🇷 Exclusive Distributor in Iran

Fardad Azma Rad Co. is the exclusive representative of AB Analitica in Iran, supplying REALQUALITY RS-WT-1 to hematology,
oncology, and molecular diagnostic laboratories nationwide. The company provides:

• Guaranteed authenticity and original sourcing
• Full technical and scientific support by trained specialists
• Hands-on user training for accurate WT1 quantification
• Reliable supply chain and fast delivery services across Iran

For laboratories seeking a standardized and clinically validated solution for WT1 monitoring,
REALQUALITY RS-WT-1 offers a complete, trusted, and high-performance workflow.

Download Catalog